In conclusion, our meta-analysis indicates that metformin is associated with a reduction in risk of colorectal adenoma incidence in individuals with T2DM, compared with insulin treatment which significantly increases the risk of colon adenoma. This evidence concerns the gene INS and colorectal adenoma.